Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|
MDA-MB-231 | BMS-265246 | 0.01 | 0.8279 | 0.00829 |
MDA-MB-231 | BMS-265246 | 0.01 | 0.8622 | 0.01399 |
MDA-MB-231 | BMS-265246 | 0.031622777 | 0.7312 | 0.01220 |
MDA-MB-231 | BMS-265246 | 0.031622777 | 0.7116 | 0.00891 |
MDA-MB-231 | BMS-265246 | 0.031622777 | 0.8293 | 0.01571 |
MDA-MB-231 | BMS-265246 | 0.1 | 0.6754 | 0.01343 |
MDA-MB-231 | BMS-265246 | 0.1 | 0.7757 | 0.01171 |
MDA-MB-231 | BMS-265246 | 0.1 | 0.7241 | 0.00696 |
MDA-MB-231 | BMS-265246 | 0.316227766 | 0.6079 | 0.02329 |
MDA-MB-231 | BMS-265246 | 0.316227766 | 0.6554 | 0.01915 |
MDA-MB-231 | BMS-265246 | 0.316227766 | 0.6957 | 0.02106 |
MDA-MB-231 | BMS-265246 | 1.0 | 0.5028 | 0.02390 |
MDA-MB-231 | BMS-265246 | 1.0 | 0.4395 | 0.02583 |
MDA-MB-231 | BMS-265246 | 1.0 | 0.6056 | 0.02456 |
MDA-MB-231 | BMS-265246 | 3.16227766 | 0.2927 | 0.03896 |
MDA-MB-231 | BMS-265246 | 3.16227766 | 0.3202 | 0.04322 |
MDA-MB-231 | BMS-265246 | 3.16227766 | 0.4411 | 0.03813 |
MDA-MB-231 | BMS-265246 | 10.0 | 0.2144 | 0.04744 |
MDA-MB-231 | BMS-265246 | 10.0 | 0.1827 | 0.06353 |
MDA-MB-231 | BMS-265246 | 10.0 | 0.2296 | 0.05870 |
MDA-MB-231 | Ulixertinib | 0.001 | 1.0443 | -0.00117 |
MDA-MB-231 | Ulixertinib | 0.001 | 1.0550 | -0.00015 |
MDA-MB-231 | Ulixertinib | 0.001 | 1.0265 | 0.00098 |
MDA-MB-231 | Ulixertinib | 0.003162278 | 1.0305 | 0.00018 |
MDA-MB-231 | Ulixertinib | 0.003162278 | 1.0620 | 0.00144 |